Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEGAFOX-E in elderly first-line metastatic colorectal cancer
2008-001355-21Phase 2Terminated
- Sponsor
- ITMO University
- Start
- Dec 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab, tegafur + uracil, oxaliplatin and levoleucovorin in metastatic colorectal adenocarcinoma (mCRC), colon adenocarcinoma and rectal adenocarcinoma, sponsored by ITMO University. Primary endpoint: overall response rate. Started Dec 2008; status: terminated.
02
Drugs
cetuximabtegafur + uraciloxaliplatinlevoleucovorin
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)colon adenocarcinomarectal adenocarcinoma
Beyond the preview
Go deeper on 2008-001355-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001355-21.